Literature DB >> 2832826

Compilation of DNA strand exchange sites for non-homologous recombination in somatic cells.

A K Konopka1.   

Abstract

DNA sequences of 496 somatic cell illegitimate crossing over regions were compiled and analyzed. Sites for non-homologous recombination on linear DNAs transfected into mammalian cells (Transfected Linear DNAs; TLD) were analyzed separately from the remaining illegitimate recombination regions (IRR). Trinucleotides that are preferentially cleaved by rat liver topoisomerase I in vitro (CAT, CTY, GTY, RAT where R = purine, Y = pyrimidine) were present in the 10 base pair (bp) vicinity of the cross-over sites in 92% of IRR and 93% of TLD. Multiple repeats of these trinucleotides have been observed in 39% of IRR and 38% of TLD. Runs of five or more contiguous purines (or pyrimidines on the complementary strand) were found in 26% of IRR and 14% of TLD. Adenine-Thymine rich regions of five or more bases were found in 14% of IRR and 21% of TLD. Alternating purine-pyrimidine tracks longer than four nucleotides in length were found in 11% of IRR, though only in 4% of TLD. I discuss the possible biological significance of these findings and present an appendix containing the sequences in the 10 bp vicinity of the non-homologous recombination sites analyzed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832826      PMCID: PMC338168          DOI: 10.1093/nar/16.5.1739

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  98 in total

1.  A gene deletion ending at the midpoint of a repetitive DNA sequence in one form of hereditary persistence of fetal haemoglobin.

Authors:  P Jagadeeswaran; D Tuan; B G Forget; S M Weissman
Journal:  Nature       Date:  1982-04-01       Impact factor: 49.962

2.  DNA sequence homology and chromosomal deletion at a site of SV40 DNA integration.

Authors:  J R Stringer
Journal:  Nature       Date:  1982-03-25       Impact factor: 49.962

3.  DNA sequences of polyoma virus early deletion mutants.

Authors:  N Smolar; B E Griffin
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

4.  Recombination in SV40-infected cells: viral DNA sequences at sites of circularization of transfecting linear DNA.

Authors:  M Woodworth-Gutai
Journal:  Virology       Date:  1981-03       Impact factor: 3.616

5.  Recognition sites of eukaryotic DNA topoisomerase I: DNA nucleotide sequencing analysis of topo I cleavage sites on SV40 DNA.

Authors:  K A Edwards; B D Halligan; J L Davis; N L Nivera; L F Liu
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

6.  Nucleotide sequence analysis of the linked left and right hand terminal regions of adenovirus type 5 DNA present in the transformed rat cell line 5RK20.

Authors:  L Visser; A C Reemst; A D van Mansfeld; T H Rozijn
Journal:  Nucleic Acids Res       Date:  1982-04-10       Impact factor: 16.971

7.  Site of linkage between adenovirus type 12 and cell DNAs in hamster tumour line CLAC3.

Authors:  R Deuring; U Winterhoff; F Tamanoi; S Stabel; W Doerfler
Journal:  Nature       Date:  1981-09-03       Impact factor: 49.962

8.  Genomic arrangement of an adenovirus-simian virus 40 hybrid virus, Ad2+ND4del.

Authors:  H Westphal
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

9.  Endodeoxyribonuclease activity associated with Rauscher murine leukemia virus.

Authors:  J J Kopchick; J Harless; B S Geisser; R Killam; R R Hewitt; R B Arlinghaus
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

10.  Integrated simian virus 40 DNA: nucleotide sequences at cell-virus recombinant junctions.

Authors:  J R Stringer
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

View more
  19 in total

1.  Diversity of hepatitis B virus X gene-related transcripts in hepatocellular carcinoma: a novel polyadenylation site on viral DNA.

Authors:  C Hilger; I Velhagen; H Zentgraf; C H Schröder
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection.

Authors:  S B Ward; S L Morrison
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

3.  Topoisomerase I-mediated integration of hepadnavirus DNA in vitro.

Authors:  H P Wang; C E Rogler
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells.

Authors:  K A Shera; C A Shera; J K McDougall
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Vertebrate protamine gene evolution I. Sequence alignments and gene structure.

Authors:  R Oliva; G H Dixon
Journal:  J Mol Evol       Date:  1990-04       Impact factor: 2.395

6.  Non-recombinant background in gene targeting: illegitimate recombination between a hpt gene and a defective 5' deleted nptII gene can restore a Kmr phenotype in tobacco.

Authors:  M J de Groot; R Offringa; J Groet; M P Does; P J Hooykaas; P J van den Elzen
Journal:  Plant Mol Biol       Date:  1994-07       Impact factor: 4.076

7.  Homologous illegitimate random integration of foreign DNA into the X chromosome of a transgenic mouse line.

Authors:  Bowen Yan; Defa Li; Kemian Gou
Journal:  BMC Mol Biol       Date:  2010-08-13       Impact factor: 2.946

8.  Mutant woodchuck hepatitis virus genomes from virions resemble rearranged hepadnaviral integrants in hepatocellular carcinoma.

Authors:  M C Kew; R H Miller; H S Chen; B C Tennant; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Detection and sequence analysis of hepatitis B virus integration in peripheral blood mononuclear cells.

Authors:  T Laskus; M Radkowski; L F Wang; M Nowicki; J Rakela
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus.

Authors:  S E Gitelman; J Bristow; W L Miller
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.